Fatigue News and Research

RSS

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

The U.S. Food and Drug Administration today expanded the approval of Xeljanz (tofacitinib) to include adults with moderately to severely active ulcerative colitis. Xeljanz is the first oral medication approved for chronic use in this indication.

30 May 2018

Growth hormone shows potential to completely transform treatment for stroke survivors

Less fatigue and better recovery of cognitive abilities such as learning and memory. These may be the results of growth hormone treatment after a stroke, an experimental study of mice published in the journal Stroke suggests.

30 May 2018

Stroke patients more likely to suffer from insomnia, shows study

Stroke patients experience sustained problems with insomnia potentially reducing their ability to relearn key skills and putting them at increased risk of depression, a new study in the journal Scientific Reports finds.

30 May 2018

Radiotherapy drug used for treating rare neuroendocrine cancers can be safe, effective for patients

A radiotherapy drug that treats the rare neuroendocrine cancers pheochromocytoma and paraganglioma can be both effective and safe for patients, according to the findings of a multi-center trial led by researchers in the Abramson Cancer Center of the University of Pennsylvania.

30 May 2018

New findings could help fine-tune treatment for cancer patients

Cancer therapies that cut off blood supply to a tumor could be more effective in combination with existing chemotherapeutic drugs - according to new research from the University of East Anglia.

25 May 2018

AACN outlines evidence-based protocols and clinical strategies to manage alarms

Clinical alarms are designed to alert clinicians to changes in their patients' conditions, but their sheer numbers and resulting noise instead pose a significant threat to patient safety, according to the American Association of Critical-Care Nurses.

25 May 2018

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

The U.S. Food and Drug Administration today approved Palynziq (pegvaliase-pqpz) for adults with a rare and serious genetic disease known as phenylketonuria (PKU).

25 May 2018

NIH commences first-in-human trial evaluating experimental treatment for Ebola

A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland.

24 May 2018

Celgene to share new and updated data around novel hematological therapies

Celgene Corporation today announced that data from a broad range of early and late stage studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 23rd European Hematology Association annual meeting in Stockholm, Sweden, from June 14-17, 2018.

22 May 2018

FDA approves new drug to treat thrombocytopenia in adults with chronic liver disease

The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure. This is the first drug approved by the FDA for this use.

22 May 2018

Smart technology helps improve outcomes for patients with head and neck cancer

A federally funded, randomized clinical trial of 357 people receiving radiation for head and neck cancer, using mobile and sensor technology to remotely monitor patient symptoms, resulted in less severe symptoms related to both the cancer and its treatment (both general and cancer-related).

17 May 2018

Minimizing dehydration without over-drinking

Proper hydration is one of the most important aspects of healthy physical activity. Drinking the right amount of fluids before, during and after physical activity is vital to providing your body the fluids it needs to perform properly.

16 May 2018

Familial Chylomicronemia Syndrome: How HCP’s can Support Patients with Rare Diseases

Dr Robert Cramb gives an introduction to the rare disease FCS, and how HCP's can best advise and support patients with the condition.

15 May 2018

Study shows consumer sleep technology needs further validation

According to a position statement from the American Academy of Sleep Medicine, consumer sleep technology must be cleared by the Food and Drug Administration and rigorously tested if it is intended to diagnose or treat sleep disorders.

15 May 2018

Doctors use new non-invasive approach to treat nasal obstruction

Researchers at The Ohio State University Wexner Medical Center are exploring how small changes in the nasal cavity impact airflow and quality of life.

14 May 2018

Working overtime may negatively influence collaboration between nurses and physicians

Working overtime may negatively influence nurses' collaboration with fellow nurses and physicians, finds a new study by researchers at NYU Rory Meyers College of Nursing.

11 May 2018

Obesity linked with worse symptoms for lupus patients

In a recent Arthritis Care & Research study of 148 women with lupus, obesity was linked with worse disease activity, depressive symptoms, and symptoms of pain and fatigue. The association was consistent across different definitions of obesity.

10 May 2018

Johns Hopkins researchers identify protein clumps in diseased hearts

Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

9 May 2018

Expert provides tips to help nurses cope with night shifts and fatigue

Finding creative ways to recruit and retain nurses at a Reno, Nevada, hospital led Barbara Hobbs, assistant dean of the SDSU College of Nursing Rapid City Site, to pursue research on the impact of shift work.

9 May 2018

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

The U.S. Food and Drug Administration approved Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for the treatment of anaplastic thyroid cancer (ATC) that cannot be removed by surgery or has spread to other parts of the body (metastatic), and has a type of abnormal gene, BRAF V600E (BRAF V600E mutation-positive).

8 May 2018

Fatigue News and Research

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

Growth hormone shows potential to completely transform treatment for stroke survivors

Stroke patients more likely to suffer from insomnia, shows study

Radiotherapy drug used for treating rare neuroendocrine cancers can be safe, effective for patients

New findings could help fine-tune treatment for cancer patients

AACN outlines evidence-based protocols and clinical strategies to manage alarms

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

NIH commences first-in-human trial evaluating experimental treatment for Ebola

Celgene to share new and updated data around novel hematological therapies

FDA approves new drug to treat thrombocytopenia in adults with chronic liver disease

Smart technology helps improve outcomes for patients with head and neck cancer

Minimizing dehydration without over-drinking

Familial Chylomicronemia Syndrome: How HCP’s can Support Patients with Rare Diseases

Study shows consumer sleep technology needs further validation

Doctors use new non-invasive approach to treat nasal obstruction

Working overtime may negatively influence collaboration between nurses and physicians

Obesity linked with worse symptoms for lupus patients

Johns Hopkins researchers identify protein clumps in diseased hearts

Expert provides tips to help nurses cope with night shifts and fatigue

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News